Brown & Brown Sinks 5% on Q3 Revenue Miss, 1.2% Organic Growth in “Challenging Rate Environment”

Brown & Brown (BRO) reported Q3 revenue of $1.7B, missing estimates of $1.76B. Organic growth was 1.2%, with 7.4% total growth driven by acquisitions. Adjusted EBITDAC margin declined to 34.6% from 36.6%. Management expects improved organic growth in 2027, but shares fell 5%.

Original reporting
Published Oct 28, 2026, 4:39 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 4:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Brown & Brown Sinks 5% on Q3 Revenue Miss, 1.2% Organic Growth in “Challenging Rate Environment” — source image
Decision brief

The 30-second read

$BROBearishHigh
01

Why it matters

The miss may trigger short‑term selling pressure but could be mitigated by future organic growth improvements.

02

Market read

Earnings miss with a 5% price drop provides a clear trading signal for BRO.

03

What to watch

Potential upside from the Accession acquisition integration and upcoming specialty segment recovery.

Relevance 8/10Novelty 8/10Timing: after-hours reaction

Background

Brown & Brown is a U.S. insurance brokerage that posted a mixed Q3 result, with revenue growth driven mainly by acquisitions.

Company-level read

Ticker impact

$BROBearishHigh confidence
Context

Brown & Brown reported Q3 revenue of $1.7B, missing the $1.76B estimate and causing a 5% share decline.

Expected impact

downward pressure as investors price in the revenue shortfall and slower organic growth.

Evidence & confidence

The earnings miss is the first report of the quarter, the stock fell 5% on the news, and guidance for 2027 remains modest.

Market effects

Insurance brokerage sector may see broader scrutiny on organic growth rates as rates cool.

U.S. market participants may adjust exposure to mid‑cap insurance brokers.

Limited to U.S. equities; no immediate global macro effect.

Counterpoint

The stock could rebound if the acquisition synergies materialize faster than expected.

Key entities

  • Brown & Brown

    U.S. insurance brokerage (ticker BRO).

  • J. Powell Brown

    CEO of Brown & Brown who commented on the challenging rate environment.

Related articles

$BROHighAI 8/10

Why Brown & Brown Stock Slumped by 5% Today

Brown & Brown (BRO) stock fell 5% after Q3 earnings missed estimates. Revenue rose 7% YoY to $1.73B, below the $1.76B consensus. GAAP net income increased 6% to $240M, while adjusted EPS grew 2% to $1.07, missing the $1.09 estimate. The company cited a challenging rate environment and attributed some growth to its Accession acquisition, but organic revenue grew only 1% YoY to $1.46B.

$BROMed

Brown & Brown Inc (BRO) (Q3 2026) Earnings Call Highlights: Revenue Up 7.4%

Brown & Brown Inc (BRO) reported Q3 2026 revenue up 7.4% to $1.07B, but adjusted EBITDAC margin fell 200 bps to 34.6%. Specialty Distribution organic revenue declined 0.8%, missing expectations due to competition and pricing pressures. The company anticipates further declines in Q4 and faces ongoing litigation impacts. Integration costs for Accession have increased to $250-300M.

$BROMed

What Brown & Brown (BRO) Said on Its Q3 Earnings Call

Brown & Brown (BRO) reported Q3 earnings, noting market shifts in California and Texas, and pricing pressures in commercial earthquake business. The company expects 2027 growth of 2%-4% for retail and 1%-3% for specialty distribution. Accession acquisition raised synergy targets to $50M for 2026 and $175M by 2028. AI initiatives are expanding across the company, with tools like Claude and COMPASS being deployed. The board increased the dividend by 9%.

$BROHighAI 8/10

Brown & Brown (BRO) Q3 2026 Earnings Call Transcript

Brown & Brown (BRO) reported Q3 2026 revenues of $1.7B, up 7.4% YoY. Organic revenue grew 1.2%, while adjusted EBITDAC margin fell 200 bps to 34.6%. Adjusted EPS rose 2% to $1.07. The company raised its dividend by 9%, marking 33 consecutive years of increases. Retail segment outperformed expectations, while specialty distribution faced headwinds. The company repurchased $750M in shares YTD, including $250M in Q3.